Emotion-focused treatment for self-criticism in a nonclinical population: A randomized controlled trial.

Self-criticism is a transdiagnostic phenomenon associated with different psychopathological manifestations in clinical and nonclinical samples. This fact has led to an increase in research on its measurement and treatment. This study seeks to examine the effects of emotion-focused therapy on self-criticism in a nonclinical population through pretreatment, posttreatment, and follow-up questionnaires.

Measuring Parental Response Styles to Child Stress in Severe Pediatric Illness: A Validation Study.

Background: Pediatric illnesses not only impose physical challenges on affected children, but also profoundly impact their emotional well-being. Understanding how parents respond to their children's psychological distress during medical experiences is crucial for enhancing the overall support provided to these families.

Aim: This study evaluated the internal structure of the Parental Response Styles Questionnaire (PRSQ), designed to differentiate parental responses to psychological distress in children with pediatric illnesses.

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain.

Introduction: Hereditary angioedema (HAE) is a rare genetic disease that impairs quality of life and could be life-threatening. The aim of this study was to apply a multicriteria decision analysis to assess the value of three long-term prophylactic (LTP) therapies for HAE in Spain.

Methods: A multidisciplinary committee of 10 experts assessed the value of lanadelumab (subcutaneous use), C1-inhibitor (C1-INH; intravenous), and danazol (orally), using placebo as comparator.

[Design and validation of a scale to measure nomophobia among children 9-13 years old].

Objective: To design and validate a nomophobia scale in children aged 9-13 years.

Design: Cross-sectional descriptive observational study. SITE: The pilot study was carried out in December 2019 with students from a school in Ávila and another in Madrid.

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.

Background: The efficacy and safety of disease-modifying therapies (DMTs) in multiple sclerosis (MS) are well known; however, owing to their high costs, determining real-world outcomes is essential to evaluate the cost-effectiveness of different therapeutic strategies. This study aimed to investigate the variability in the annual cost of DMTs associated with a relapse-free patient in a representative population cohort of relapsing-remitting MS (RRMS), and whether this could serve as an appropriate health indicator.

Methods: We analyzed the patients followed up in our MS clinic during the years 2016 and 2019, and selected patients belonging to our health district diagnosed with RRMS.